COMMUNIQUÉS West-GlobeNewswire

-
Melinta Therapeutics Announces Appointment of Bruce L. Downey to Board of Directors
31/10/2018 -
ChromaDex to Report Third Quarter 2018 Financial Results on Wednesday, November 7, 2018
31/10/2018 -
Chembio Diagnostics Announces Proposed Public Offering of Common Stock
31/10/2018 -
Conformis Reports Third Quarter 2018 Financial Results and Updates Fiscal Year 2018 Guidance
31/10/2018 -
OrthoPediatrics Corp. Reports Third Quarter 2018 Financial Results
31/10/2018 -
TRACON to Report Third Quarter 2018 Company Highlights and Financial Results on November 7, 2018
31/10/2018 -
Dermira to Report Third Quarter 2018 Results and Host Conference Call on Wednesday, November 7, 2018
31/10/2018 -
Editas Medicine to Host Conference Call Discussing Third Quarter 2018 Corporate Update and Results
31/10/2018 -
Sientra to Participate in Upcoming Investor Conferences
31/10/2018 -
Cerecor Announces Submission of Three Orphan Drug Designation Requests for Substrate Replacement Therapies to treat Congenital Disorders of Glycosylation
31/10/2018 -
CV Sciences, Inc. to Host Third Quarter 2018 Financial Results Conference Call on Wednesday, November 7, 2018
31/10/2018 -
Soricimed Publishes New Research Validating TRPV6 as a Therapeutic Target for Ovarian Cancer
31/10/2018 -
Ira Duarte Promoted to Chief Financial Officer of Veloxis Pharmaceuticals A/S
31/10/2018 -
Tabula Rasa HealthCare to Participate in Upcoming Investor Conference
31/10/2018 -
Eurobio Scientific : LEVEE DE FONDS OBLIGATAIRE D'UN MONTANT DE 2,5 M€ AVEC VATEL DIRECT
31/10/2018 -
Sandoz receives US FDA approval for biosimilar Hyrimoz(TM) (adalimumab-adaz)
31/10/2018 -
Change to Executive Management: Anders Hedegaard leaves as CEO of GN Hearing
31/10/2018 -
Orion Biotechnology Completes Scientific Advice Meeting with MHRA
31/10/2018 -
NeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable Technology
31/10/2018
Pages